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In the previous paper we demonstrated that uridine-
5*-b-1-(5-sulfonic acid) naphthylamidate (UDPAmNS) is
a stacked and quenched fluorophore that shows sever-
alfold enhancement of fluorescence in a stretched con-
formation. UDPAmNS was found to be a powerful com-
petitive inhibitor (Ki 5 0.2 mM) for UDP-glucose-4-
epimerase from Escherichia coli. This active site-
directed fluorophore assumed a stretched conformation
on the enzyme surface, as was evidenced by full en-
hancement of fluorescence in saturating enzyme con-
centration. Complete displacement of the fluorophore
by UDP suggested it to bind to the substrate binding site
of the active site. Analysis of inactivation kinetics in
presence of a,b-diones such as phenylglyoxal, cyclohax-
anedione, and 2,3-butadione suggested involvement of
the essential arginine residue in the overall catalytic
process. From spectral analysis, loss of activity could
also be directly correlated with modification of only one
arginine residue. Protection experiments with UDP
showed the arginine residue to be located in the uridyl
phosphate binding subsite. Unlike the native enzyme,
the modified enzyme failed to show any enhancement of
fluorescence with UDPAmNS clearly demonstrating the
role of the essential arginine residue in stretching and
binding of the substrate. The potential usefulness of
such stacked and quenched nucleotide fluorophores has
been discussed.
UDP-glucose-4-epimerase (EC 5.1.3.2, henceforth called epi-
merase) catalyzes a freely reversible reaction between UDP-
glucose and UDP-galactose. This enzyme of the galactose met-
abolic pathway is essential for the biosynthesis of numerous
galactoconjugates in all cell types studied so far. This epime-
rase has emerged as the prototype of a new class of oxidoreduc-
tases in which the coenzyme NAD, noncovalently but firmly
bound to the apoenzyme, acts as a true cofactor and not as a
cosubstrate as in the case of classical dehydrogenases. Several
apparently unrelated enzymes such as S-adenosylhomocystein-
ase (EC 3.3.1.1), dTDPglucose oxidoreductase (EC 4.1.1.46),
and UDP-glucuronate decarboxylase (EC 4.1.1.35) mechanisti-
cally belong to this new class of oxidoreductases. In each case
catalysis is initiated by reduction of enzyme-bound NAD. The
oxidized substrate then undergoes chemical transformation, if
necessary, on the enzyme surface before the hydride is ste-
reospecifically returned back and the product is released (1, 2).
In case of the epimerase, UDP-4-ketohexose and NADH have
been unambiguously demonstrated to be the reaction interme-
diates on the enzyme surface. Stereospecific return of the hy-
dride from NADH to the opposite face of the oxidized hexose
moiety completes the catalytic process (1–7). Most of the stud-
ies on mechanism, quaternary structure, and active site have
been carried out with the Kluyveromyces fragilis and Esche-
richia coli enzymes. Extensive chemical modification studies
with the yeast enzyme revealed the requirement of one essen-
tial thiol (8, 9) one histidine (10), and an arginine (11) in the
overall catalytic process. The primary sequence and the three-
dimensional structure of this enzyme are not known. The ho-
modimeric 79-kDa E. coli holoenzyme, on the other hand, has
recently been cloned, expressed, and crystallized in various
catalytically inactive forms (12–14). Although no modification
work has been reported with the enzyme, a reasonably clear
picture of the active site has emerged at 1.83 resolution (13,
14). The substrate analog UDP-benzene seems to be in a
stretched conformation, and amino acid residues involved in
various binding interactions can be tentatively identified. It is
imperative that modification studies be carried out with the E.
coli enzyme to specify and confirm the tentative roles of these
amino acid residues residing at the active site.
In the previous paper we demonstrated that uridine-
59-diphosphoro-b-1-(5-sulfonic acid) naphthylamidate (UDP-
AmNS)1 in aqueous solution behaves as a quenched fluoro-
phore because of its predominantly stacked conformation.
Quenching is fully released when complete destacking takes
place (15). To explore the possibility of whether such designed
fluorophores can be used to probe conformational transitions of
a putative ligand as it interacts with its target protein, we used
UDPAmNS as the probe and the E. coli epimerase as the model
target enzyme for this purpose. We first show that UDPAmNS
is indeed a substrate site-directed probe for this enzyme. Fur-
thermore, the probe assumes a fully stretched conformation on
the enzyme surface, as is evidenced by total dequenching of
fluorescence on interaction with the enzyme. Finally, we dem-
onstrate the essential requirement of at least one arginine
residue in this binding process. The reliability of these results
is confirmed from the available x-ray data.
MATERIALS AND METHODS
All biochemicals unless otherwise stated were purchased from
Sigma. [1-14C]Phenylglyoxal (2.17 mCi/mmol) was purchased from
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Bhaba Atomic Research Center. Common chemicals were of analytical
grade and purchased from Merck.
Absorption measurements were done in a Hitachi U-3200 spectro-
photometer, and fluorescence measurements were done in a Hitachi
F-4010 spectrofluorimeter.
Enzymes and Assays—Highly purified and essentially homogenous
UDP-glucose-4-epimerase was prepared from E. coli according to the
method of Wilson and Hogness (3). The specific activity of the enzyme
was 150–160 units/mg of protein, where 1 unit of enzyme could convert
1 mmol of UDP-galactose to UDP-glucose in 1 min. Epimerase activity
was routinely determined by the use of the coupled assay system of
Wilson and Hogness (3). In this case, UDP-glucose, the product of
epimerization, is immediately converted to UDP-glucuronic acid by
coupling the reaction with UDP-glucose dehydrogenase and NAD. The
assay mixture consisted of 0.1 M glycylglycine buffer, pH 8.8, 0.25 mM
NAD, 0.16 units of UDP-glucose dehydrogenase, and the requisite
amount of epimerase. The reaction was initiated by addition of UDP-
galactose, and increase in absorbance attributable to formation of
NADH was measured at 340 nm for second and fifth minutes. Because
the synthetic fluorophore itself had a significant absorbance at 340 nm,
a two-step assay system was used whenever necessary. This assay has
been described in detail earlier (17). Briefly, in a total volume of 200 ml
containing 0.2 M glycylglycine buffer, pH 8.8, and 30 mg of bovine serum
albumin, the requisite amount of epimerase was taken, and reaction
was initiated with UDP-galactose. The reaction was terminated after 5
min by rapid addition of chloroform and vigorous shaking. The mixture
was then centrifuged. In the second stage, an appropriate aliquot from
the top aqueous layer was taken out to estimate the amount of UDP-
glucose formed by adding it in a medium containing UDP-glucose de-
hydrogenase and NAD and observing the change in absorbance at 340
nm. A control blank without epimerase was parallely run. Protein was
estimated by the method of Lowry et al. (18). For all stoichiometric
calculations, the molecular weight for the epimerase was assumed to be
79,000 (12).
Synthetic Fluorophores and Fluorescence Measurements—UDP-
AmNS and other AmNS derivatives were synthesized and purified
according the methods described in our preceeding paper (15). Wher-
ever necessary, excess ligands and reagents were removed from reac-
tion mixtures by Sephadex G-50 spin column centrifugation as de-
scribed by Maniatis et al. (19).
Modification Experiments—Modification with phenyglyoxal was car-
ried out in 0.05 M potassium phosphate buffer, pH 8.0. The reagent was
dissolved in dimethyl sulfoxide, which had no effect on the stability of
the enzyme. Modification with 1,2-cyclohexanedione and 2,3-butanedi-
one was carried out in 0.05 M sodium borate buffer, pH 8.8. Borate had
no inhibitory effect on the enzyme. All experiments, unless otherwise
stated were carried out at 28 °C. All kinetics of inactivation were
followed by measurement of residual activities of reaction mixtures,
withdrawn at intervals and suitably diluted. The modifying reagents at
the concentrations used in the assay medium did not have any effect on
UDP-glucose dehydrogenase, the coupling enzyme of the coupled assay
procedure. In reactivation experiments the inactivated epimerase was
treated with neutralized 0.5 M hydroxylamine, which on dilution during
assay had no effect on the activity of the control enzyme.
Incorporation of [14C]Phenylglyoxal—[1-14C] Phenylglyoxal incorpo-
ration studies were performed to determine the stoichiometry of the
reaction of phenylglyoxal with arginine residues of the epimerase. The
enzyme (0.6 mg/ml) in 0.5 M potassium phosphate buffer, pH 8.0, was
incubated with 2.5 mM [1-14C] phenylglyoxal (1.2 3 106 cpm/mmol) for
45 min. Excess reagent and ligand were removed by spin column cen-
trifugation, and the eluates were measured for enzyme activity, protein
concentration, and radioactivity.
Estimation of Quantum Enhancement Q—This was done according
the procedure of Mas and Colman (20) using the following equation:
1/(F/F0 2 1) 5 Kd/QznzP 1 1/Q, where F0 and F represent the fluores-
cence intensity of UDPAmNS in the absence and in presence of the E.
coli epimerase after subtracting that attributable to epimerase, and P is
the epimerase concentration. The intercept of the plot of 1/(F/F0 2 1)
versus 1/P gives 1/Q, where Q is the quantum enhancement or the
enhancement that would occur when all the fluorophore is bound to the
protein.
RESULTS
UDPAmNS Is a Probe for the Active Site of E. coli Epime-
rase—We first investigated whether UDPAmNS can be used as
a probe for the active site of the E. coli enzyme. Both the K.
fragilis and the E. coli enzymes are known to be competitively
inhibited by UMP and UDP (21, 22). UDPAmNS was also found
to be a strict competitive inhibitor for the epimerase (Fig. 1)
and hence a probe for the active site of the enzyme. Clearly,
substitution of the hexose moiety by the bulky AmNS did not
present any major steric problem for specific interaction of this
ligand to the substrate-binding site of the enzyme. This is
consistent with the reaction mechanism that assumes free ro-
tation of the ketohexose moiety during catalysis (2). Further-
more, earlier observations had shown that considerable modi-
fication of the hexose moiety or its substitution by other
moieties can be effected without hampering the binding prop-
erty of the substrate (23–25). The Ki for UDPAmNS was cal-
culated to be 0.20 mM, which compares very well with the Ki
obtained with other such similar aromatic analogs of UDP such
as p-bromoacetamidophenyluridyl pyrophosphate (0.21 mM)
and p-nitrophenyluridyl pyrophosphate (0.21 mM) (24, 25).
Conformational Transition of UDPAmNS on the Enzyme
Surface—Fig. 2A shows the fluorescence spectra of UDPAmNS
(9.3 mM) as the concentration of epimerase was progressively
increased in the cuvette. Quite evidently, the stacked and
quenched fluorophore assumes a stretched conformation on
interaction with the enzyme and hence is relieved of its quench-
ing (15). Fig. 2A, inset, shows that extrapolation at infinite
enzyme concentration when all the fluorophores have inter-
acted with the enzyme results in a 8-fold increase in fluores-
cence, a value that agrees excellently with the value obtained
for the fully unstacked fluorophore in isopropanol and dimeth-
ylsulfoxide or after phosphodiesterase bond cleavage (previous
paper, Fig. 1; Ref. 15).
Fig. 2B shows complete displacement of UDPAmNS from the
enzyme surface by UDP. This is additional evidence to show
that the fluorophore is interacting with the enzyme exclusively
at the substrate binding site. The native E. coli holoenzyme
displays a weak intrinsic fluorescence (lem 5 453 nm) when
excited at 360 nm. This is probably attributable to the varying
amounts of NADH that are known to be bound to the dimeric
apoenzyme when purified from overexpressed E. coli (26). We
shall now show that by using this fluorophore one can uncover
very conveniently amino acid residues that are essential for the
binding of the substrate.
Modification Studies with a,b-Diones—Because the sub-
FIG. 1. Inhibition kinetics of epimerase with UDPAmNS. The
inhibition kinetics was carried out by two-step assay method as de-
scribed under “Materials and Methods.” UDPAmNS concentrations for
the different sets are no UDPAmNS (l), 0.23 mM (E), and 0.46 mM (M).
Blank was also done containing no epimerase. The Ki for UDPAmNS
was 0.20 mM.
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strate for epimerase is negatively charged at the cellular pH,
we decided to explore the possible involvement of cationic ar-
ginine residue(s) in the binding of the substrate. We had earlier
shown the presence of an essential arginine residue at the
substrate binding site of the K. fragilis enzyme (11). Incubation
of epimerase with phenylglyoxal led to a progressive loss of
enzyme activity. The inactivation followed a pseudo-first order
kinetics. A plot of logK versus log of reagent concentration (27)
resulted in a straight line with a slope close to unity (Fig. 3A),
indicating that at least 1 mol of phenylglyoxal/mol of enzyme
was required to produce inactivation. Because phenylglyoxal
has occasionally been shown to react with residues other than
arginine (28), two highly selective arginine-modifying reagents,
cyclohexanedione (29) and butanedione (30), were also used to
modify the enzyme. In both cases phosphate buffer was re-
placed by borate to stabilize the adducts (28). With cyclohex-
anedione also, epimerase was completely inactivated following
a pseudo-first order kinetics, and a reaction order of 1 was
obtained (Fig. 3B). Similar results were obtained with 2,3-
butanedione (data not shown). Notwithstanding some limita-
tions in this kinetic method (31), because the kinetic order of
inactivation was close to 1 in all cases, the minimal number of
arginine residue(s) that were involved in the inactivation proc-
ess could be taken to be 1.
A specific test for modification of essential arginine resi-
due(s) is the regeneration of activity in presence of hydroxyla-
mine (29). The enzyme modified by cyclohexanedione and in-
activated to ,10% of its original activity could be completely
reactivated when the inactivated enzyme was diluted 20-fold in
0.5 M neutralized hydroxylamine in 50 mM potassium phos-
phate buffer, pH 7.0 (data not shown). In contrast, when the
enzyme was inactivated with phenylglyoxal, it could not be
significantly reactivated. Such irreversible modification is in-
dicative of the formation of a stable diphenylglyoxal derivative
(32). To establish the stoichiometry of phenylglyoxal to argi-
nine also as the number of arginine residues that are modified
during the process of inactivation, both spectrophotometric
analysis and radiolabeling with [1-14C]phenylglyoxal were car-
ried out. For this purpose, epimerase (0.8 mg/ml) was incu-
bated with phenylglyoxal (2.5 mM) in 0.05 mM potassium phos-
phate buffer, pH 8.0, for 45 min at 28 °C. The inactivated
enzyme (.95%) was freed of excess reagent in a spin column
and a differential spectrum was obtained with the untreated
enzyme as the control. The differential spectrum with lmax at
250 nm was characteristic of a diphenylglyoxal derivative (data
not shown). Using a molar absorption coefficient of 11,000 M/cm
for the diderivative (32), 3.1 arginine residues were found to be
modified in the process. In a parallel experiment with
[1-14C]phenylglyoxal, 5.8 mol of phenylglyoxal was found to be
incorporated per mole of the enzyme under identical conditions,
confirming the stoichiometry of phenylglyoxal to arginine to
be 2:1.
The spectral signal at 250 nm for the formation of the diphe-
nylglyoxal derivative provided a handle to directly relate the
extent of arginine modification with loss of activity. Fig. 4
shows that although all the three arginine residues are reac-
tive, the loss of activity versus number of arginine residues
modified extrapolates to 1 at zero activity of the enzyme. The
excellent correspondence between this direct method and the
kinetic method leaves little doubt that at least 1 arginine
residue is intimately associated with the overall catalytic proc-
ess. The usefulness of such a combination of methods was first
demonstrated by Hayman and Coleman (31) for isocitrate
dehydrogenase.
Location of the Essential Arginine Residue—Protection ex-
periments with UMP or UDP convincingly demonstrated that
the essential arginine residue is indeed located in the substrate
binding region of the active site. Fig. 5 shows that the rate of
inactivation of phenylglyoxal is progressively decreased as the
concentration of UMP is increased. A plot of t1/2 of inactivation
against the concentration of 59-UMP was linear (Fig. 5, inset).
The intercept on the abscissa of such a plot gives the dissocia-
tion constant (Kd) of the enzyme-protecting agent complex (27).
The Kd of the epimerase-UMP complex was calculated to be 1.9
mM, which is in excellent agreement with the Kd for UMP (1.9
mM) obtained kinetically (22). The experiment with UDP also
gave strong protection. Based on this protection experiment,
the essential arginine residue was placed in the binding subsite
for the nucleotide phosphates.
The Essential Arginine Residue Is Critical for Stretching and
Binding of the Substrate—To ascertain the specific role of the
essential arginine residue located at the uridylphosphoryl
FIG. 2. A, destacking of UDPAmNS on interaction with epimerase.
UDPAmNS (9.3 mM) and E. coli epimerase (27.8 mM) were taken in 100
mM potassium phosphate buffer, pH 8.0, and excited at 360 nm, and the
emission spectrum was scanned. It was then serially diluted with 9.3
mM UDPAmNS in the same buffer to vary the enzyme concentration
keeping the fluorophore concentration constant and similarly scanned
at every step. The spectra at different epimerase concentrations (mM) in
the presence of 9.3 mM UDPAmNS were: a, 27.83; b, 25.05; c, 22.26; d,
19.48; e, 16.70; f, 13.91; g, 11.13; h, 8.35; i, 5.57; and j, no epimerase.
Inset, plot of 1/(F/F0 2 1) against 1/P. Here F0 and F represent the
fluorescence intensity of UDPAmNS in the absence and presence of the
epimerase at an excitation wavelength of 360 nm after subtracting that
attributable to free protein. P is the epimerase concentration. The
intercept of the plot on the 1/(F/F0 2 1) axis gives 1/Q, where Q is the
quantum enhancement or the enhancement that would occur when all
the fluorophore is bound to the protein (see “Materials and Methods). B,
displacement of UDPAmNS from the epimerase by 59-UDP. E. coli
epimerase (20 mM) and UDPAmNS (9.3 mM) were taken in 200 ml of 100
mM potassium phosphate buffer, pH 8.0, and excited at 360 nm, and the
emission spectrum was taken (c). To it were added small aliquots (1–10
ml) of concentrated stock solution of 59-UDP, and the spectrum was
similarly scanned. The final concentration of 59-UDP are represented by
2 (d), 4 (e), 8 (f), and 16 (g) mM and (h) 1 mM. The fluorescence spectra
of free enzyme and free UDPAmNS in buffer are represented by a and
b, respectively.
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FIG. 5. Protection against inactivation by phenylglyoxal by
uridyl phosphates. Epimerase (10 mg/ml) in 0.05 mM potassium phos-
phate buffer, pH 8.0, was treated with 2.5 mM phenylglyoxal in the
absence or presence of increasing concentrations of 59-UMP. a–e, UMP
(mM) concentrations of 0, 1.5, 3, 6, and 9, respectively; f, kinetics in the
presence of UDP (4 mM); g, untreated epimerase control. Inset, plot of
half-time of inactivation (t1/2) against concentration of UMP. The slope
of the plot gives the Kd of the enzyme-UMP complex.
1.25 mM (E), 2.5 mM (f), 5 mM (), and 10 mM (l). Inset, plot of log
psuedo-first order rate constant (K) of cyclohexanedione inactivation
reaction versus log of cyclohexanedione concentration. The slope of the
plot is 0.8.
FIG. 3. A, inactivation of epimerase by phenylglyoxal. The enzyme
(7.5 mg/ml) was incubated with varying concentrations of phenylglyoxal
in 0.05 M potassium phosphate buffer, pH 8.0, at 28 °C. At the indicated
intervals, aliquots were withdrawn for measuring enzyme activity. The
phenylglyoxal concentrations in the various runs were 0.25 mM (E ), 0.5
mM (), 1 mM (l), 2 mM () and 5 mM (M). Inset, plot of puedo-first order
rate constant (K) versus log of phenylglyoxal concentration. The slope of
the plot is 0.75. B, inactivation of epimerase by 1,2-cyclohexanedione.
The enzyme (6 mg/ml) was incubated with increasing concentrations of
cyclohexanedione in 0.05 M sodium borate buffer, pH 8.8. Aliquots were
withdrawn at the indicated intervals for measuring residual activity of
the enzyme. The cyclohexanedione concentrations at various runs were
FIG. 4. Correlation between loss of activity and number of
arginine residues modified on phenylglyoxal treatment of the
epimerase. The enzyme (0.58 mg/ml) was treated with 2.5 mM phenyl-
glyoxal in 0.05 M potassium phosphate buffer, pH 8.0, containing 1 mM
EDTA, at 28 °C for 60 min. At intervals of 5, 10, 15, 20, 30, 40, 50, and
60 min aliquots were withdrawn and subjected to spin column centrif-
ugation to terminate the inactivation reaction. Small aliquots of the
column eluates were removed for activity measurement and protein
estimation. The bulk of the eluates were subjected to difference scan
(230–330 nm) against control enzyme treated in an identical fashion.
Fractions of arginine residues modified were determined from the mo-
lar extinction coefficient for diphenylglyoxalated arginine at 250 nm
(e 5 11,000 M/cm).
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binding subsite, the enzyme inactivated with phenylglyoxal
(.95%) was allowed to interact with UDPAmNS. Fig. 6 shows
that the quenched fluorophore failed to show significant en-
hancement of fluorescence with the modified enzyme. Clearly,
in this case, the stacked fluorophore failed to bind and undergo
transition to a stretched conformation on the enzyme surface.
In contrast, interaction with the native enzyme that served as
the control resulted in severalfold enhancement of fluorescence
of UDPAmNS. Furthermore, UDPAmNS could be completely
displaced from the enzyme surface by UDP (Fig. 6, trace e),
confirming its specific interaction at the substrate binding site
of the enzyme. The essential arginine residue is, therefore,
critically involved not only in the binding but also in the
destacking or stretching of this substrate analog on the enzyme
surface. The conformational change that the ligand underwent
on the enzyme surface could be monitored quite conveniently
only because this transition was accompanied by significant
enhancement of fluorescence attributable to release of stacking
and consequential absence of collisional quenching.
DISCUSSION
In the previous paper we had shown that when a uridine
nucleotide is derivatized with a suitable aromatic fluorophore
such as AmNS via a phosphoramidate bond through the termi-
nal phosphate, it takes a stacked conformation in aqueous
solution that is in rapid equilibrium with its extended form
(15). The dynamic collisional quenching of fluorescence in the
stacked form should make such strongly quenched fluoro-
phores eminently suitable as probes for protein or enzyme
studies provided such designed molecules satisfy the following
conditions. First, the derivatized probe must be true structural
analogs of the desired ligand so that specificity is retained, and
second, the probe on interaction with the target protein should
take a destacked conformation so that the resultant enhance-
ment of fluorescence can be a direct monitor of the conforma-
tional transition of the probe and hence of its interaction with
the protein. Our present work shows that UDPAmNS satisfies
both the conditions when E. coli epimerase is used as the
enzyme target. Although the competitive nature of inhibition
(Fig. 1) suggests it to be an active site-directed analog, maxi-
mum enhancement of fluorescence when all the molecules of
the fluorophores are bound to the enzyme (Fig. 2A) clearly
demonstrates a destacked or stretched conformation of the
substrate analog on the enzyme surface. These results agree
very well with the published x-ray data of the holoenzyme as it
is co-crystallized with UDP-phenol or with other abortive forms
of the enzyme (12–14). Because the destacking energy was
calculated to be 2.3 Kcal/mol for UDPAmNS (previous paper;
Ref. 15), the binding energy for the UDP moiety of the sub-
strate may be assumed to have a minimal value of that order.
Kinetic analysis with a, b-dicarbonyl reagents (Fig. 3), fol-
lowed by estimation of arginine residues that can be directly
correlated with total loss of activity (Fig. 4), clearly shows that
one arginine residue is essential for the overall catalytic activ-
ity. Complete regeneration of activity of 1,2-cyclohexanedione-
inactivated enzyme by hydroxylamine and of 2,3-butanedione-
inactivated enzyme on removal of borate by dilution (see text)
is also consistent with modification of an essential arginine
residue on the enzyme surface. Nearly complete protections
provided both by UMP and by UDP against modification by
phenylglyoxal (Fig. 5) strongly suggest that the essential argi-
nine residue is located in the uridylphosphoryl binding subsite
of the active site and is probably involved in the productive
binding of the substrate with the enzyme. Using UDPAmNS as
the active site-directed designed probe, we could at this stage
convincingly demonstrate that the essential arginine residue is
critically needed both for binding and for stretching of the
substrate (Fig. 6).
Fig. 7 provides a schematic representation of the overall
process. The stacked and quenched fluorophore in the buffered
aqueous solution assumes a stretched conformation on the
enzyme surface that leads to dequenching of fluorescence. The
essential arginine residue is obligatorily needed in this binding
process. These results fit exceedingly well with the published
FIG. 7. Schematic diagram depicting the binding of UDPAmNS
at the substrate binding site of E. coli epimerase.
FIG. 6. Interaction of UDPAmNS with native and modified
epimerase. E. coli epimerase (27 mM) was incubated with 5 mM phe-
nylglyoxal in 100 mM potassium buffer, pH 8.0, for 2 h till complete
inactivation. It was then passed through a Sephadex G-50 spin column
to remove excess reagent. 27 mM unmodified enzyme was also similarly
passed through the spin column. At an excitation wavelength of 360 nm
the following spectra were taken in the same buffer as above: a, un-
modified epimerase (27 mM); b, UDPAmNS (9.3 mM); c, unmodified
epimerase (27 mM) and UDPAmNS (9.3 mM); d, displacement of
UDPAmNS with 10 mM UDP; e, after total displacement of UDPAmNS
with 1 mM UDP; f, phenylglyoxal-treated epimerase (27 mM) and
UDPAmNS (9.3 mM).
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x-ray and sequence homology data (13, 14). Resolution at 32.0
of the holoenzyme co-crystallized with UDP had earlier shown
that apart from four molecules of water, Asn-179, Leu-200,
Ala-216, and Arg-292 are in a bonding distance of UDP. More
importantly, the oxyanion of a-phosphate of UDP has a poten-
tial bonding interaction with the guanidino nitrogen of Arg-
292. This, most likely, is the essential arginine residue uncov-
ered by our modification studies. Interestingly, this arginine
residue is conserved across the phylogenetic scale for epime-
rase, which includes clones from several organisms such as
bacteria, yeast, and mammals (14).
Our present study with UDPAmNS as a representative com-
pound for stacked and quenched fluorophores shows that such
designed nucleotide fluorophores can possibly be of consider-
able use in following ligand-protein interactions in several
classes of proteins of great biological interest. Several ATPases,
kinases, and G-proteins in general show that nucleotides take
a stretched conformation on the protein surface (16, 33). In
principle, the conformational transition of such a quenched
fluorophore as it interacts with its target protein can thus be
used to study many aspects of the structure-function relation-
ship of these enzymes or proteins. An anticipated advantage in
terms of ligand specificity for such synthetic fluorophores may
be attributable to the fact that both the base and the ribose
moieties are left unaltered during the derivatization process.
Like other extrinsic fluorophores, such fluorophores can also be
used for energy transfer studies, because the tryptophan emis-
sion spectrum overlaps the absorption spectrum of these po-
tential fluorophores. These fluorophores can also be uniquely
useful as sensors for the formation of substrate binding or
ligand binding sites in protein-folding studies. Finally, search
for lead compounds for drug development may be facilitated by
rapid fluorimetric monitoring of the displacement of stretched
fluorophores from the binding site of target proteins, e.g. G-
proteins, by an array of synthetic molecules generated by com-
binatorial methods or extracts from plant sources.
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